- Home
- GOVX vs LIQT Comparison
GOVX vs LIQT Comparison
Compare GOVX & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- LIQT
- Stock Information
- Founded
- GOVX 2001
- LIQT 2004
- Country
- GOVX United States
- LIQT Denmark
- Employees
- GOVX N/A
- LIQT N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- GOVX Health Care
- LIQT Technology
- Exchange
- GOVX Nasdaq
- LIQT Nasdaq
- Market Cap
- GOVX 16.8M
- LIQT 16.1M
- IPO Year
- GOVX N/A
- LIQT N/A
- Fundamental
- Price
- GOVX $0.60
- LIQT N/A
- Analyst Decision
- GOVX Strong Buy
- LIQT Strong Buy
- Analyst Count
- GOVX 3
- LIQT 1
- Target Price
- GOVX $10.67
- LIQT $3.60
- AVG Volume (30 Days)
- GOVX 1.2M
- LIQT 16.8K
- Earning Date
- GOVX 11-11-2025
- LIQT 11-13-2025
- Dividend Yield
- GOVX N/A
- LIQT N/A
- EPS Growth
- GOVX N/A
- LIQT N/A
- EPS
- GOVX N/A
- LIQT N/A
- Revenue
- GOVX $6,143,044.00
- LIQT $15,459,242.00
- Revenue This Year
- GOVX N/A
- LIQT $36.89
- Revenue Next Year
- GOVX N/A
- LIQT $16.33
- P/E Ratio
- GOVX N/A
- LIQT N/A
- Revenue Growth
- GOVX 1943.07
- LIQT N/A
- 52 Week Low
- GOVX $0.43
- LIQT $1.34
- 52 Week High
- GOVX $3.88
- LIQT $3.35
- Technical
- Relative Strength Index (RSI)
- GOVX 47.47
- LIQT 54.48
- Support Level
- GOVX $0.52
- LIQT $2.65
- Resistance Level
- GOVX $0.62
- LIQT $3.35
- Average True Range (ATR)
- GOVX 0.05
- LIQT 0.20
- MACD
- GOVX 0.01
- LIQT -0.00
- Stochastic Oscillator
- GOVX 71.36
- LIQT 31.11
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.